ACHP

CAS No. 406208-42-2

ACHP( —— )

Catalog No. M33778 CAS No. 406208-42-2

ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 103 In Stock
10MG 154 In Stock
25MG 255 In Stock
50MG 365 In Stock
100MG 621 In Stock
200MG 1014 In Stock
500MG 2027 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ACHP
  • Note
    Research use only, not for human use.
  • Brief Description
    ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β.
  • Description
    ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-α and IKK-β. ACHP has anti-HIV-1 activity and inhibits HIV-1 long terminal repeat (LTR)-driven gene expression through inhibition of NF-κB activation, inhibits TNF-α-induced NF-κB (p65) recruitment to the HIV-1 LTR, and inhibits TNF-α-induced NF-κB (p65) recruitment to the HIV-1 LTR. ACHKP has anti-HIV-1 activity and inhibits TNF-α-induced recruitment of NF-κB (p65) to the HIV-1 LTR.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    IκB/IKK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    406208-42-2
  • Formula Weight
    364.44
  • Molecular Formula
    C21H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=C(N=C(C=C1C2CCNCC2)C=3C(O)=CC=CC3OCC4CC4)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bay 65-1942

    A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM.

  • BAY32-5915

    BAY32-5915 is a selective inhibitor of IKKalpha.

  • HOIPIN-8 sodium

    HOIPIN-8 is a potent inhibitor of the linear ubiquitin chain assembly complex (LUBAC) with an IC50 of 11 nM. As a derivative of HOIPIN-1, it exhibits 255-fold greater inhibition of both petit-LUBAC and TNF-α-mediated NF-κB activation compared to HOIPIN-1.